Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-012-1294-5.

Title:
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology | Cancer Immunology, Immunotherapy
Description:
Accumulating evidence indicates that myeloid cells are critically involved in the pathophysiology of human cancers. In contrast to the well-characterized tumor-associated macrophages, the significance of granulocytes in cancer has only recently begun to emerge. A number of studies found increased numbers of neutrophil granulocytes and granulocytic myeloid-derived suppressor cells (GrMDSCs) both in the peripheral blood and in the tumor tissues of patients with different types of cancer. Most importantly, granulocytes have been linked to poor clinical outcome in cancer patients which suggests that these cells might have important tumor-promoting effects. In this review, we will address in detail the following major topics: (1) neutrophils and GrMDSCs in the peripheral blood of cancer patients—phenotype and functional changes; (2) neutrophils and GrMDSCs in the tumor tissue—potential mechanisms of tumor progression and (3) relevance of neutrophils and GrMDSCs for the clinical outcome of cancer patients. Furthermore, we will discuss the advantages and disadvantages of the current strategies used for identification and monitoring of human MDSCs. We propose a six-color immunophenotyping protocol that discriminates between monocytic MDSCs (MoMDSCs), two subsets of GrMDSCs and two subsets of immature myeloid cells in human cancer patients, thus, allowing for an improved characterization and understanding of these multifaceted cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, google, scholar, pubmed, cancer, cas, cells, patients, neutrophils, suppressor, cell, myeloidderived, neutrophil, carcinoma, human, tumor, immunol, res, oncol, myeloid, granulocytes, clin, int, blood, ratio, brandau, peripheral, lung, function, clinical, lang, factor, survival, renal, dumitru, trellakis, hepatocellular, gabrilovich, lee, immunother, granulocytic, increased, progression, subsets, biol, melanoma, bruderek, lymphocyte, elevated, predicts,

Topics {✒️}

activated cd11b + cd15 + granulocytes increase immunosuppressive cd14 + hla-drlow/- monocytes myeloid-derived suppressor cells granulocyte-derived hydrogen peroxide cd8-positive t-cell ratio cd15 +/cd16low human granulocytes month download article/chapter high-risk melanoma treated neutrophil-derived april concentrated tumor tissue—potential mechanisms hyaluronan-mediated tlr4/pi3 stephan lang & sven brandau reduced interferon-alpha signaling myeloid suppressor cells important tumor-promoting effects myeloid cell-mediated immunosuppression diaz-montero cm small-cell lung cancer neutrophil elastase-mediated degradation hif-1alpha regulates function intratumoral cd66b-positive neutrophil immature myeloid cells myeloid regulatory cells article cancer immunology il-10-secreting neutrophils differentiated full article pdf poor prognostic factor renal cell carcinoma plasmacytoid dendritic cells privacy choices/manage cookies hla-dr neck cancer cells hepatocellular carcinoma cells halazun kj t-cell function neutrophil granulocytes promote de gruijl td nuclear beta-catenin oral cavity cancer pre-treatment neutrophil infiltrating neutrophils mediate reduced tumor growth independent prognostic factor excellent technical support myeloid cells cells correlate il-8 induces exocytosis malignant cell intravasation neutrophil-lymphocyte ratio breast cancer patients

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
         description:Accumulating evidence indicates that myeloid cells are critically involved in the pathophysiology of human cancers. In contrast to the well-characterized tumor-associated macrophages, the significance of granulocytes in cancer has only recently begun to emerge. A number of studies found increased numbers of neutrophil granulocytes and granulocytic myeloid-derived suppressor cells (GrMDSCs) both in the peripheral blood and in the tumor tissues of patients with different types of cancer. Most importantly, granulocytes have been linked to poor clinical outcome in cancer patients which suggests that these cells might have important tumor-promoting effects. In this review, we will address in detail the following major topics: (1) neutrophils and GrMDSCs in the peripheral blood of cancer patients—phenotype and functional changes; (2) neutrophils and GrMDSCs in the tumor tissue—potential mechanisms of tumor progression and (3) relevance of neutrophils and GrMDSCs for the clinical outcome of cancer patients. Furthermore, we will discuss the advantages and disadvantages of the current strategies used for identification and monitoring of human MDSCs. We propose a six-color immunophenotyping protocol that discriminates between monocytic MDSCs (MoMDSCs), two subsets of GrMDSCs and two subsets of immature myeloid cells in human cancer patients, thus, allowing for an improved characterization and understanding of these multifaceted cells.
         datePublished:2012-06-13T00:00:00Z
         dateModified:2012-06-13T00:00:00Z
         pageStart:1155
         pageEnd:1167
         sameAs:https://doi.org/10.1007/s00262-012-1294-5
         keywords:
            Neutrophils
            MDSC
            Tumor progression
            Immunophenotyping
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1294-5/MediaObjects/262_2012_1294_Fig1_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:61
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Claudia A. Dumitru
               affiliation:
                     name:University of Duisburg-Essen
                     address:
                        name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katrin Moses
               affiliation:
                     name:University of Duisburg-Essen
                     address:
                        name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sokratis Trellakis
               affiliation:
                     name:University of Duisburg-Essen
                     address:
                        name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephan Lang
               affiliation:
                     name:University of Duisburg-Essen
                     address:
                        name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sven Brandau
               affiliation:
                     name:University of Duisburg-Essen
                     address:
                        name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
      description:Accumulating evidence indicates that myeloid cells are critically involved in the pathophysiology of human cancers. In contrast to the well-characterized tumor-associated macrophages, the significance of granulocytes in cancer has only recently begun to emerge. A number of studies found increased numbers of neutrophil granulocytes and granulocytic myeloid-derived suppressor cells (GrMDSCs) both in the peripheral blood and in the tumor tissues of patients with different types of cancer. Most importantly, granulocytes have been linked to poor clinical outcome in cancer patients which suggests that these cells might have important tumor-promoting effects. In this review, we will address in detail the following major topics: (1) neutrophils and GrMDSCs in the peripheral blood of cancer patients—phenotype and functional changes; (2) neutrophils and GrMDSCs in the tumor tissue—potential mechanisms of tumor progression and (3) relevance of neutrophils and GrMDSCs for the clinical outcome of cancer patients. Furthermore, we will discuss the advantages and disadvantages of the current strategies used for identification and monitoring of human MDSCs. We propose a six-color immunophenotyping protocol that discriminates between monocytic MDSCs (MoMDSCs), two subsets of GrMDSCs and two subsets of immature myeloid cells in human cancer patients, thus, allowing for an improved characterization and understanding of these multifaceted cells.
      datePublished:2012-06-13T00:00:00Z
      dateModified:2012-06-13T00:00:00Z
      pageStart:1155
      pageEnd:1167
      sameAs:https://doi.org/10.1007/s00262-012-1294-5
      keywords:
         Neutrophils
         MDSC
         Tumor progression
         Immunophenotyping
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-012-1294-5/MediaObjects/262_2012_1294_Fig1_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:61
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Claudia A. Dumitru
            affiliation:
                  name:University of Duisburg-Essen
                  address:
                     name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katrin Moses
            affiliation:
                  name:University of Duisburg-Essen
                  address:
                     name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sokratis Trellakis
            affiliation:
                  name:University of Duisburg-Essen
                  address:
                     name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephan Lang
            affiliation:
                  name:University of Duisburg-Essen
                  address:
                     name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sven Brandau
            affiliation:
                  name:University of Duisburg-Essen
                  address:
                     name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:61
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Duisburg-Essen
      address:
         name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
         type:PostalAddress
      name:University of Duisburg-Essen
      address:
         name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
         type:PostalAddress
      name:University of Duisburg-Essen
      address:
         name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
         type:PostalAddress
      name:University of Duisburg-Essen
      address:
         name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
         type:PostalAddress
      name:University of Duisburg-Essen
      address:
         name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Claudia A. Dumitru
      affiliation:
            name:University of Duisburg-Essen
            address:
               name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:Katrin Moses
      affiliation:
            name:University of Duisburg-Essen
            address:
               name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:Sokratis Trellakis
      affiliation:
            name:University of Duisburg-Essen
            address:
               name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:Stephan Lang
      affiliation:
            name:University of Duisburg-Essen
            address:
               name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:Sven Brandau
      affiliation:
            name:University of Duisburg-Essen
            address:
               name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
      name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
      name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
      name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
      name:Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(286)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.52s.